Form 4 for CDNA CareDx, Inc.
Accepted 2021-10-06 00:00:00 ET · period of report 2021-10-05 · accession 0001217234-21-000225 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-06 | 2021-10-05 | CDNA | Maag Peter | Executive COB, Dir | S - Sale+OE | $64.67 | -10.0K | 346.5K | -3% | -$646.7K |
| DM | 2021-10-06 | 2021-10-05 | CDNA | Maag Peter | Executive COB, Dir | M - OptEx | $18.17 | +10.0K | 351.8K | +3% | +$181.7K |
| DM | 2021-10-06 | 2021-10-05 | CDNA | Maag Peter | Executive COB, Dir | M - OptEx | $0.00 | -10.0K | 25.0K | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-05 | S | D | 1,163 | $65.90 | 341,756 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.59 to $66.25, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
| 2 | Common | Common Stock | 2021-10-05 | S | D | 3,612 | $64.95 | 342,919 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.55 to $65.53, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
| 3 | Common | Common Stock | 2021-10-05 | S | D | 5,225 | $64.21 | 346,531 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.52 to $64.52, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
| 4 | Common | Common Stock | 2021-10-05 | M | A | 3,727 | $12.24 | 346,409 | D | — | — | |
| 5 | Common | Common Stock | 2021-10-05 | M | A | 926 | $6.31 | 342,682 | D | — | — | |
| 6 | Common | Common Stock | 2021-10-05 | M | A | 5,347 | $24.35 | 351,756 | D | — | — | |
| 7 | Derivative | Employee Stock Option (right to buy) | 2021-10-05 | M | D | 5,347 | $0.00 | 56,906 | D | $24.35 · — to 2030-02-03 | 5,347 Common Stock | (F8) 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter. |
| 8 | Derivative | Employee Stock Option (right to buy) | 2021-10-05 | M | D | 926 | $0.00 | 8,941 | D | $6.31 · — to 2028-01-19 | 926 Common Stock | (F6) 1/4th of the shares subject to the option shall vest on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. |
| 9 | Derivative | Employee Stock Option (right to buy) | 2021-10-05 | M | D | 3,727 | $0.00 | 25,000 | D | $12.24 · — to 2028-06-29 | 3,727 Common Stock | (F7) 1/4th of the shares subject to the option shall vest on June 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. |